Toward an integrated software platform for systems pharmacology

Biopharmaceutics and Drug Disposition

Volumn 34, Issue 9, 2013, Pages 508-526

  Ghosh, Samik ^a,b   Matsuoka, Yukiko ^a,c   Asai, Yoshiyuki ^d   Hsin, Kun Yi ^d   Kitano, Hiroaki ^a,b,d  

^a Systems Biology Institute   (Japan)

^b Institute of Physical and Chemical Research   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY   (Japan)

Author keywords

integrated software platform; systems biology; systems pharmacology

Indexed keywords

ARTICLE; BIOLOGY; COMPUTATIONAL FLUID DYNAMICS; COMPUTER MODEL; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; INFORMATION PROCESSING; INTELLIGENCE; METABOLIC REGULATION; PHARMACOLOGY; PHASE SPACE ANALYSIS; SENSITIVITY ANALYSIS; SIMULATION; SYSTEMS BIOLOGY; SYSTEMS PHARMACOLOGY;

COMPUTER SIMULATION; HUMANS; PHARMACOLOGY; SOFTWARE; SYSTEMS BIOLOGY;

EID: 84890553923     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.1875     Document Type: Article

References (92)

1. Kitano H,. Systems biology: a brief overview. Science 2002; 295: 1662-1664.
2. Kitano H,. Computational systems biology. Nature 2002; 420: 206-210.
3. Kitano H,. Perspectives on systems biology. Future Generat Comput Syst 2000; 18: 199-216.
4. Ideker T, Galitski T, Hood L,. A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2001; 2: 343-372. doi: 10.1146/annurev. genom.2.1.343.
5. Evans D, Hagiu A, Schmalensee R,. Invisible Engines: How Software Platforms Drive Innovation and Transform Industries. MIT Press: USA, 2006. http://mitpress.mit.edu/books/invisible-engines
6. Lee TL,. Big data: open-source format needed to aid wiki collaboration. Nature 2008; 455: 461. doi: 10.1038/455461c.
7. Galperin MY, Cochrane GR,. The 2011 nucleic acids research database issue and the online molecular biology database collection. Nucleic Acids Res 2011; 39: D1-D6. doi: 10.1093/nar/gkq1243.
8. Mayer G,. Data management in systems biology I-Overview and bibliography CoRR 2009; abs/0908.0411.
9. Zhao J, Miles A, Klyne G, Shotton D,. Linked data and provenance in biological data webs. Brief Bioinform 2009; 10: 139-152. doi: 10.1093/bib/bbn044.
10. Van Deun K, Smilde AK, van der Werf MJ, Kiers HA, Van Mechelen I,. A structured overview of simultaneous component based data integration. BMC Bioinformatics 2009; 10: 246. doi: 10.1186/1471-2105-10-246.
11. Brown F,. Saving big pharma from drowning in the data pool. Drug Discov Today 2006; 11: 1043-1045. doi: 10.1016/j.drudis.2006.10.002.
12. Bry F, Kröger P,. A computational biology database digest: data, data analysis, and data management. Distrib Parallel Databases 2003; 13: 7-42.
13. Field D, Tiwari B, Snape J,. Bioinformatics and data management support for environmental genomics. PLoS Biol 2005; 3: e297. doi: 10.1371/journal.pbio. 0030297.
14. Keator DB,. Management of information in distributed biomedical collaboratories. Methods Mol Biol 2009; 569: 123. doi: 10.1007/978-1-59745-524- 4-1.
15. Brazma A, Krestyaninova M, Sarkans U,. Standards for systems biology. Nat Rev Genet 2006; 7: 593-605. doi: 10.1038/nrg1922.
16. Oinn T, Addis M, Ferris J, et al,. Taverna: a tool for the composition and enactment of bioinformatics workflows. Bioinformatics 2004; 20: 3045-3054. doi: 10.1093/bioinformatics/bth361.
17. Saltz J, Oster S, Hastings S, et al,. caGrid: design and implementation of the core architecture of the cancer biomedical informatics grid. Bioinformatics 2006; 22: 1910-1916. doi: 10.1093/bioinformatics/btl272.
18. Lee S, Wang TD, Hashmi N, Cummings MP,. Bio-STEER: a semantic web workflow tool for grid computing in the life sciences. Future Generations Computer Systems 2007; 23 (3): 497-509.
19. Gehlenborg N, O'Donoghue SI, Baliga NS, et al,. Visualization of omics data for systems biology. Nat Methods 2010; 7: S56-S68. doi: 10.1038/nmeth.1436.
20. Krzywinski M, Schein J, Birol I, et al,. Circos: an information aesthetic for comparative genomics. Genome Res 2009; 19: 1639-1645. doi: 10.1101/gr.092759.109.
21. Kohl M, Wiese S, Warscheid B,. Cytoscape: software for visualization and analysis of biological networks. Methods Mol Biol 2011; 696: 291-303. doi: 10.1007/978-1-60761-987-1-18.
22. Schadt EE, Friend SH, Shaywitz DA,. A network view of disease and compound screening. Nat Rev Drug Discov 2009; 8: 286-295. doi: 10.1038/nrd2826.
23. van't Veer LJ, Dal H, van der Vijver MJ, et al,. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-536. doi: 10.1038/415530a.
24. Altshuler D, Daly MJ, Lander ES,. Genetic mapping in human disease. Science 2008; 322: 881-888. doi: 10.1126/science.1156409.
25. Dewan A, Liu M, Hartman S, et al,. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006; 314: 989-992. doi: 10.1126/science.1133807.
26. Yang Z, Camp NJ, Sun H, et al,. A variant of the HTRA1 gene increases susceptibility to agerelated macular degeneration. Science 2006; 314: 992-993. doi: 10.1126/science.1133811.
27. Chesler EJ, Lu L, Shou S, et al,. Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nat Genet 2005; 37: 233-242. doi: 10.1038/ng1518.
28. Monks SA, Leonardson A, Zhu H, et al,. Genetic inheritance of gene expression in human cell lines. Am J Hum Genet 2004; 75: 1094-1105. doi: 10.1086/426461.
29. Morley M, Molony CM, Weber TM, et al,. Genetic analysis of genome-wide variation in human gene expression. Nature 2004; 430: 743-747. doi: 10.1038/nature02797.
30. Zhu J, Lum PY, Lamb J, et al,. An integrative genomics approach to the reconstruction of gene networks in segregating populations. Cytogenetic Genome Res 2004; 105: 363-374. doi: 10.1159/000078209.
31. Zhu J, Wiener MC, Zhang C, et al,. Increasing the power to detect causal associations by combining genotypic and expression data in segregating populations. PLoS Comput Biol 2007; 3: e69. doi: 10.1371/journal.pcbi.0030069.
32. Zhu J, Zhang B, Smith EN, et al,. Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. Nat Genet 2008; 40: 854-861. doi: 10.1038/ng.167.
33. Margolin AA, Nemenman I, Basso K, et al,. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 2006; 7 (Suppl 1): S7. doi: 10.1186/1471-2105-7-S1-S7.
34. Faith JJ, Hayete B, Thaden JT, et al,. Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles. PLoS Biol 2007: 5: e8. doi: 10.1371/journal.pbio.0050008.
35. Shen-Orr SS, Milo R, Mangan S, Alon U,. Network motifs in the transcriptional regulation network of Escherichia coli. Nat Genet 2002; 31: 64-68. doi: 10.1038/ng881.
36. Alon U,. Network motifs: theory and experimental approaches. Nature Rev Genet 2007; 8: 450-461. doi: 10.1038/nrg2102.
37. Fadda A, Fierro AC, Lemmens K, Monsieurs P, Engelen K, Marchal K,. Inferring the transcriptional network of Bacillus subtilis. Mol BioSystems 2009; 5: 1840-1852. doi: 10.1039/b907310h.
38. Cho BK, Zengler K, Qiu Y, et al,. The transcription unit architecture of the Escherichia coli genome. Nat Biotechnol 2009; 27: 1043-1049. doi: 10.1038/nbt.1582.
39. Mendoza-Vargas A, Olvera L, Olvera M, et al,. Genome-wide identification of transcription start sites, promoters and transcription factor binding sites in E. coli. PLoS One 2009; 4: e7526. doi: 10.1371/journal.pone.0007526.
40. Lemmens K, De Bie T, Dhollander T, et al,. DISTILLER: a data integration framework to reveal condition dependency of complex regulons in Escherichia coli. Genome Biol 2009; 10: R27. doi: 10.1186/gb-2009-10-3-r27.
41. Ferrucci D, Brown E, Chu-Carroll J, et al,. Building Watson: an overview of the DeepQA project. AI Magazine 2010; 31: 59-79.
42. Oda K, Kitano H,. A comprehensive map of the toll-like receptor signaling network. Mol Syst Biol 2006; 2: 2006.0015. doi:msb4100057 [pii] 10.1038/msb4100057 [doi].
43. Oda K, Matsuoka Y, Funahashi A, Kitano H,. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 2005; 1: 2005 0010. doi:msb4100014 [pii] 10.1038/msb4100014 [doi].
44. Caron E, Ghosh S, Matsuoka Y, et al,. A comprehensive map of the mTOR signaling network. Mol Syst Biol 2010; 6: 453. doi:msb2010108 [pii] 10.1038/msb.2010.108.
45. Kaizu K, Ghosh S, Matsuoka Y, et al,. A comprehensive molecular interaction map of the budding yeast cell cycle. Mol Syst Biol 2010; 6: 415, doi:msb201073 [pii] 10.1038/msb.2010.73.
46. Bauer-Mehren A, Furlong LI, Sanz F,. Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol 2009; 5: 290. doi:msb200947 [pii] 10.1038/msb.2009.47.
47. Hucka M, Finney A, Bornskin BJ, et al,. Evolving a lingua franca and associated software infrastructure for computational systems biology: the Systems Biology Markup Language (SBML) project. Systems Biol (Stevenage) 2004; 1: 41-53.
48. Le Novere N, Hucke M, Mi H, et al,. The systems biology graphical notation. Nat Biotechnol 2009; 27: 735-741. doi: 10.1038/nbt.1558.
49. Le Novere N, Finney A, Hucka M, et al,. Minimum information requested in the annotation of biochemical models (MIRIAM). Nat Biotechnol 2005; 23: 1509-1515. doi: 10.1038/nbt1156.
50. Kitano H, Funahashi A, Matsuoka Y, Oda K,. Using process diagrams for the graphical representation of biological networks. Nat Biotechnol 2005; 23: 961-966. doi: 10.1038/nbt1111.
51. Pico AR, Kelder T, van Iersel MP, Hanspers K, Conklin BR, Evelo C,. WikiPathways: pathway editing for the people. PLoS Biol 2008; 6: e184. doi: 10.1371/journal.pbio.0060184.
52. Mendes P, Hoops S, Sahle S, Gauges R, Dada J, Kummer U,. Computational modeling of biochemical networks using COPASI. Methods Mol Biol 2009; 500: 17-59. doi: 10.1007/978-1-59745-525-1-2.
53. Machne R, Finney A, Muller S, Lu J, Widder S, Flamm C,. The SBML ODE Solver Library: a native API for symbolic and fast numerical analysis of reaction networks. Bioinformatics 2006; 22: 1406-1407. doi: 10.1093/ bioinformatics/btl086.
54. Lopez-Aviles S, Kapuy O, Novak B, Uhlmann F,. Irreversibility of mitotic exit is the consequence of systems-level feedback. Nature 2009; 459: 592-595. doi: 10.1038/nature07984.
55. Schoeberl B, Pace EA, Fitzgerald JB, et al,. Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis. Sci Signal 2009; 2: ra31. doi: 10.1126/scisignal.2000352.
56. McAdams HH, Arkin A,. Stochastic mechanisms in gene expression. Proc Natl Acad Sci U S A 1997; 94: 814-819.
57. Ozbudak EM, Thattai M, Kurtser I, Grossman AD, van Oudenaarden A,. Regulation of noise in the expression of a single gene. Nat Genet 2002; 31: 69-73. doi: 10.1038/ng869.
58. Novak B, Tyson JJ,. Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos. J Cell Sci 1993; 106 (Pt 4): 1153-1168.
59. Tyson JJ, Chen K, Novak B,. Network dynamics and cell physiology. Nat Rev Mol Cell Biol 2001; 2: 908-916.
60. Schoeberl B, Faber AC, Li D, et al,. An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation. Cancer Res 2010; 70: 2485-2494. doi: 10.1158/0008-5472.CAN-09-3145.
61. Arkin A, Ross J, McAdams HH,. Stochastic kinetic analysis of developmental pathway bifurcation in phage lambda-infected Escherichia coli cells. Genetics 1998; 149: 1633-1648.
62. Emonet T, Macal CM, North MJ, Wickersham CE, Cluzel P,. AgentCell: a digital single-cell assay for bacterial chemotaxis. Bioinformatics 2005; 21: 2714-2721. doi: 10.1093/bioinformatics/bti391.
63. Hofestadt R, Thelen S,. Quantitative modeling of biochemical networks. Stud Health Technol Inform 2011; 162: 3-16.
64. Waltemath D, Adams R, Beard DA, et al,. Minimum Information About a Simulation Experiment (MIASE). PLoS Comput Biol 2011; 7: e1001122, doi: 10.1371/journal.pcbi.1001122.
65. Klipp ERH, Kowald A, Wierling C, Lehrach H,. Systems Biology in Practice: Concepts, Implementation and Application. John Wiley & Sons: Germany, 2005.
66. Haefner JW,. Modeling Biological Systems: Principles and Applications (1st edn). Kluwer Academic: UK, 1996.
67. Edwards JS, Palsson BO,. How will bioinformatics influence metabolic engineering? Biotechnol Bioengineer 1998; 58: 162-169.
68. Edwards JS, Ibarra RU, Palsson BO,. In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nat Biotechnol 2001; 19: 125-130. doi: 10.1038/84379.
69. Kauffman SA,. Metabolic stability and epigenesis in randomly constructed genetic nets. J Theor Biol 1969; 22: 437-467.
70. Zheng J, Zhang D, Przkycki PF, Zielinski R, Capala J, Prztycka TM,. SimBoolNet-a Cytoscape plugin for dynamic simulation of signaling networks. Bioinformatics 2010; 26: 141-142. doi: 10.1093/bioinformatics/btp617.
71. Brazma A, Hingamp P, Quackenbush J, et al,. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001; 29: 365-371. doi: 10.1038/ng1201-365.
72. Hucka M, Finney A, Sauro HM, et al,. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 2003; 19: 524-531.
73. Demir E, Cary MP, Paley S, et al,. The BioPAX community standard for pathway data sharing. Nat Biotechnol 2010; 28: 935-942. doi: 10.1038/nbt.1666.
74. Le Novere N, Hucka M, Mi H, et al,. The systems biology graphical notation. Nat Biotechnol 2009; 27: 735-741. doi:nbt.1558 [pii] 10.1038/nbt.1558 [doi].
75. Mi H, Thomas P,. PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Methods Mol Biol 2009; 563: 123-140. doi: 10.1007/978-1-60761-175-2-7.
76. Kemper B, Matsuzaki T, Matsuoka Y, et al,. PathText: a text mining integrator for biological pathway visualizations. Bioinformatics 2010; 26: i374-i381. doi: 10.1093/bioinformatics/btq221.
77. Smith DA,. Metabolism, Pharmacokinetics and Toxicity of Functional Groups Metabolism, Pharmacokinetics and Toxicity of Functional Groups. Royal Society of Chemistry Publishing: London, 2010; 61-94.
78. Pico AR, Kelder T, van Iersel MP, Hanspers K, Conklin BR, Evelo C,. WikiPathways: pathway editing for the people. PLoS Biol 2008; 6: e184. doi:08-PLBI-CP-0724 [pii] 10.1371/journal.pbio.0060184.
79. Maier H, Dohr S, Grote K, et al,. LitMiner and WikiGene: identifying problem-related key players of gene regulation using publication abstracts. Nucleic Acids Res 2005; 33: W779-782. doi: 10.1093/nar/gki417.
80. Matsuoka Y, Ghosh S, Kikuchi N, Kitano H,. Payao: a community platform for SBML pathway model curation. Bioinformatics 2010; 26: 1381-1383. doi:btq143 [pii] 10.1093/bioinformatics/btq143.
81. Kitano H, Ghosh S, Matsuoka Y,. Social engineering for virtual 'big science' in systems biology. Nat Chem Biol 2011; 7: 323-326. doi: 10.1038/nchembio.574.
82. Harrold MJ, Ramanathan M, Mager ED,. Network-based approaches in drug discovery and early development. Clin Pharmacol Ther 2013. doi: 10.1038/clpt.2013.176.
83. Wist DA, Berger IS, Iyengar R,. Systems pharmacology and genome medicine: a future perspective. Genome Med 2009; 1: 11. doi: 10.1186/gm11.
84. Berger SI, Iyengar R,. Role of systems pharmacology in understanding drug adverse events. Wiley Interdiscip Rev Syst Biol Med 2011; 3 (2): 129-135. doi: 10.1002/wsbm.114.
85. Zhao S, Iyengar R,. Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. Annu Rev Pharmacol Toxicol 2012; 52: 505-521. doi: 10.1146/annurev-pharmtox-010611-134520.
86. Jones H, Rowland-Yeo K,. Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development. CPT Pharmacometrics Syst Pharmacol 2013; 2: e63. doi: 10.1038/psp.2013.41.
87. Sorger PK, Allerheiligen RBS, et al,. Quantitative and Systems Pharmacology in the Post-genomic Era: New Approaches to Discovering Drugs and Understanding Therapeutic Mechanisms. An NIH White Paper by the QSP Workshop Group. 2011.
88. Csermely P, Korcsmáros T, Kiss HJ, London G, Nussinov R,. Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther 2013; 138 (3): 333-408. doi: 10.1016/j.pharmthera.2013.01.016.
89. Models that take drugs. The Economist report, 11 June 2005.
90. Michelson S,. Assessing the Impact of Predictive Biosimulation on Drug Discovery and Development. Journal of Bioinformatics and Computational Chemistry 2003; 1 (1): 169-177.
91. Merrimack Pharmaceuticals Initiates Enrollment In A Phase 1 Study Of MM-121, An ErbB3 Antagonist. Medical News Today, 12 August 2008.
92. Rogers M, Lyster P, Okita R,. NIH Support for the emergence of quantitative and systems pharmacology. CPT Pharmacometrics Syst Pharmacol 2013; 2: e37. doi: 10.1038/psp.2013.13.